lih.lu
Biomedical research in Luxembourg on cancer and immune disorders, translating findings into clinical applications for patients
Highlights
- Hiring13 open roles
- New on EvolcAdded 2026-10-27
About lih.lu
The Luxembourg Institute of Health (LIH) is a public biomedical research organisation focused on precision health. Its patient-centric translational research concentrates on cancer and immune-related disorders, and it uses artificial intelligence on patient-derived data to build disease knowledge intended for clinical use.
Research teams study how distinct diseases share immune-related mechanisms, with the aim of developing diagnostics, therapies and tools for personalised medicine. Priority topics include digital health, preventive medicine, clinical research and precision health. Patients, researchers, private companies and donors can take part in its work.
The institute is located in Luxembourg and organises its work into departments such as Infection & Immunity, Cancer Research and Precision Health, alongside support services. It currently recruits for postdoctoral fellows, master's internships, clinical study and regulatory roles, quality management and IT project management.
Product: Translational biomedical research in precision health, with priority areas in cancer and immune-related disorders.
Jobs at lih.lu (13)
lih.lu is hiring for 13 roles based in Luxembourg City.
Public Health Study Lead (JA/PHSL0926/AL/RES)
New on EvolcHead of Quality Management (JA/HOQM0726/FG/GM)
New on Evolc
Companies hiring like lih.lu
More biotech & pharma companies
Liminal Biosciences
Develops small-molecule therapeutics for metabolic, inflammatory and fibrotic diseases through GPCR pathwaysNew on EvolcLindus Health
Clinical development of in-licensed drug assets for biotech and pharma partners, run on an AI clinical trial platformNew on EvolcRemote-friendlyLinical
Contract research organization running clinical trials and drug development services for biopharma companiesNew on EvolcRemote-friendlyLinio Biotech
Regenerative tissue platform (Tience) for skin and soft-tissue defect treatment, used by clinicians in the NordicsNew on EvolcLINK Medical
Contract research and regulatory services for biotech, pharma and medtech companies across Northern EuropeNew on EvolcRemote-friendlyLipidica
Lipidica develops a blood-based lipidomic test for early detection of pancreatic cancer, aimed at clinical useYoung company
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Ads
- Google Analytics 4
- Google Tag Manager
- Google reCAPTCHA
- PHP
- WordPress
- jQuery